You are here » Home » Companies » Company Overview » Astrazeneca Pharma India Ltd

Astrazeneca Pharma India Ltd.

BSE: 506820 Sector: Health care
NSE: ASTRAZEN ISIN Code: INE203A01020
BSE LIVE 14:18 | 26 Sep 948.10 -7.95
(-0.83%)
OPEN

956.05

HIGH

965.00

LOW

948.10

NSE LIVE 14:19 | 26 Sep 954.80 -2.25
(-0.24%)
OPEN

960.05

HIGH

964.90

LOW

945.45

OPEN 956.05
PREVIOUS CLOSE 956.05
VOLUME 745
52-Week high 1348.00
52-Week low 948.10
P/E 180.94
Mkt Cap.(Rs cr) 2370.25
Buy Price 948.45
Buy Qty 4.00
Sell Price 956.35
Sell Qty 7.00
OPEN 956.05
CLOSE 956.05
VOLUME 745
52-Week high 1348.00
52-Week low 948.10
P/E 180.94
Mkt Cap.(Rs cr) 2370.25
Buy Price 948.45
Buy Qty 4.00
Sell Price 956.35
Sell Qty 7.00

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd

Astrazeneca Pharma India formerly known as Astra-IDL (AIL), a joint venture of Astra Zeneca, UK and Hinduja controlled IDL is a market leader in local anesthetics with xylocaine. The, UB's 100% subsidiary, UB Biotek, has tied up with the Company to market its newly-patented anti-obesity nutraceutical. The herbal product, Hydroxycitrisol, extracted from garcinia (kokum), is one of two UB techno...> More

Astrazeneca Pharma India Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   2,370
EPS - TTM () [*S] 5.24
P/E Ratio (X) [*S] 180.94
Face Value ()   2
Latest Dividend (%)   175.00
Latest Dividend Date 09 Jul 2012
Dividend Yield (%) 0.00
Book Value / Share () [*S] 62.41
P/B Ratio () [*S] 15.19
[*C] Consolidated     [*S] Standalone

Astrazeneca Pharma India Ltd - Financial Results

Particulars ( cr) Jun 2016 Jun 2015 % Chg
Net Sales 139.54 131.98 5.73
Other Income 1.56 1.71 -8.77
Total Income 141.1 133.69 5.54
Total Expenses 123.57 126.69 -2.46
Operating Profit 17.53 7 150.43
Net Profit 10.57 2.72 288.6
Equity Capital 5 5 -
> More on Astrazeneca Pharma India Ltd Financials Results

Astrazeneca Pharma India Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Granules India 121.55 0.21 2638.85
Unichem Labs. 266.00 0.45 2416.61
Suven Life Scie. 189.80 0.69 2416.15
Astrazeneca Phar 948.10 -0.83 2370.25
Novartis India 703.00 -0.04 2246.79
Marksans Pharma 52.90 10.55 2165.20
Caplin Point Lab 1335.00 -0.13 2017.18
> More on Astrazeneca Pharma India Ltd Peer Group

Astrazeneca Pharma India Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 75.00
Banks/FIs 0.06
FIIs 5.19
Insurance 0.00
Mutual Funds 7.09
Indian Public 10.66
Custodians 0.00
Other 1.99
> More on Astrazeneca Pharma India Ltd Share Holding Pattern

Astrazeneca Pharma India Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -2.38% -1.72% -1.01% -0.84%
1 Month -11.45% -10.92% 2.02% 1.89%
3 Month -11.02% -10.60% 7.37% 7.98%
6 Month -18.81% -18.09% 11.87% 13.19%
1 Year -19.37% -18.76% 9.59% 11.01%
3 Year 13.21% 13.86% 42.48% 48.49%

Astrazeneca Pharma India Ltd - STOCK STRENGTH

Today's Low/High 948.10
965.00
Week Low/High 948.10
999.00
Month Low/High 948.10
1098.00
YEAR Low/High 948.10
1348.00
All TIME Low/High 3.75
2649.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard